L’insufficienza respiratoria acuta configurata dalla SARS CoV2 può determinare danno miocardico ipossico, testimoniato dal rilascio di biomarcatori come la troponina I ed i peptidi natriuretici. Ciò è particolarmente frequente quando i profili di comorbidità condizionano coronaropatie o ipertrofia miocardica o cardiopatie di varia eziologia…
COVID-19 can vary from causing no symptoms in some people to a life-threatening illness requiring intensive care and mechanical ventilation in others. COVID-19 affects the body in many different ways, including causing blood clots such as DVTs and PEs. Thrombosis in COVID-19 may be due to direct damage to blood vessels, ‘out-of-control’ inflammation, or other mechanisms that are not completely understood…
The initial reports on the epidemiology of coronavirus disease 2019 (COVID-19) emanating from Wuhan, China, offered an ominous forewarning of the risks of severe complications in elderly patients and those with underlying cardiovascular disease, including the development of acute respiratory distress syndrome, cardiogenic shock, thromboembolic events, and death…
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with arterial and venous thrombotic complications. In a US registry of patients with coronavirus disease 2019 (COVID-19), thrombotic complications occurred in 2.6% of 229 non–critically ill hospitalized patients and in 35.3% of 170 hospitalized critically ill patients…
Il presente report descrive le caratteristiche di 55.824 pazienti deceduti e positivi a SARS-CoV-2 in Italia ed è basato sui dati aggiornati al 2 dicembre 2020 ed è stato prodotto dal Gruppo della Sorveglianza SARS-CoV-2…
Considerations and initiatives to fight the spread of SARS- CoV-2…
“Lontani, ma troppo vicini”. Questa in estrema sintesi la situazione che appena un mese fa sembrava toccarci solo marginalmente. Il vento della globalizzazione che ha rivoluzionato le nostre società con continui stravolgimenti, regalandoci in particolare la facilità di viaggiare annullando le distanze tra i diversi continenti, alla fine si è trasformato nella tempesta perfetta contro la nostra stessa Civiltà…
CLINICAL QUESTION What is the role of drug interventions in the treatment of patients with covid-19? NEW RECOMMENDATION The latest version of this WHO living guidance focuses on remdesivir, following the 15 October 2020 preprint publication of results from the WHO SOLIDARITY trial. It contains a weak or conditional recommendation against the use of remdesivir in hospitalised patients with covid-19…
The 2019 novel coronavirus, known as COVID-19, has greatly affected the way sonographers care for their patients…
In the midst of the COVID‐19 pandemic, unprecedented pressure has been added to healthcare systems around the globe. Imaging is a crucial component in the management of COVID‐19 patients. Point‐of‐care ultrasound (POCUS) such as hand‐carried ultrasound emerges in the COVID‐19 era as a tool that can simplify the imaging process of COVID‐19 patients, and potentially reduce the strain on healthcare providers and healthcare resources…
The acute respiratory illnesses caused by severe acquired respiratory syndrome corona Virus-2 (SARS-CoV-2) is a global health emergency, involving more than 8.6 million people worldwide with more than 450,000 deaths…
COVID-19 is also manifested with hypercoagulability, pulmonary intravascular coagulation, microangiopathy, and venous thromboembolism (VTE) or arterial thrombosis…
Several reports had observed a high risk of pulmonary embolism (PE) in patients with coronavirus disease 2019 (COVID‐19), most of them in the intensive care unit…
A 75-year-old man with a history of hypertension and type 2 diabetes mellitus presented to the coronavirus disease 2019 (COVID-19) outpatient clinic with a sore throat and cough for 5 days…
The 2019 novel coronavirus outbreak and its associated disease (coronavirus disease 2019 [COVID-19]) have created a worldwide pandemic…
No studies have reported the effect of the coronavirus disease 2019 (COVID-19) epidemic on patients with preexisting stroke…
Recent case-series of small size implied a pathophysiological association between coronavirus disease 2019 (COVID-19) and severe large-vessel acute ischemic stroke….
In this Commentary, we address mechanisms of stroke in patients with coronavirus disease 2019 (COVID-19) due to infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It should be noted that given the recency of the pandemic, most studies are small case series, so this evaluation should be regarded as preliminary…
Cardiovascular complications, including myocardial infarction, ischemic stroke, and pulmonary embolism, represent an important source of adverse outcomes in coronavirus disease-2019 (COVID-19)…
Coagulation abnormalities with elevated D-dimer levels have been identified as predictors of poor prognosis in patients with coronavirus disease 2019 (COVID-19) in China…